Knee-Ankle-Foot Brace for Cerebral Palsy
Trial Summary
What is the purpose of this trial?
Background: - Cerebral palsy (CP) is the most common motor disorder in children. CP often causes crouch gait, an abnormal way of walking. Knee crouch has many causes, so no single device or approach works best for everybody. This study s adjustable brace provides many types of walking assistance. Researchers will evaluate brace options to find the best solution for each participant, and whether one solution works best for the group. Objective: - To evaluate a new brace to improve crouch gait in children with CP. Eligibility: * Children 5 17 years old with CP. * Healthy volunteers 5 17 years old. Design: * All participants will be screened with medical history and physical exam. * Healthy volunteers will have 1 visit. They will do motion analysis, EMG, and EEG described below. * Participants with CP will have 6 visits. * Visit 1: \<TAB\>1. Motion analysis: Balls will be taped to participants skin. This helps cameras follow their movement. \<TAB\>2. EMG: Metal discs will be taped to participants skin. They measure electrical muscle activity. \<TAB\>3. Participants knee movement will be tested. \<TAB\>4. Participants will walk 50 meters. \<TAB\>5. Participants legs will be cast to make custom braces. * Visit 2: * Participants will wear their new braces and have them adjusted. * Steps 1 3 will be repeated. * EEG: Small metal discs will be placed on the participants scalp. They record brain waves. * Participants will have electrical stimulation of their knees and practice extending them. * Participants will take several walks with the braces in different settings. * Visits 3 5: participants will repeat the walking and some other steps from visit 2. * Visit 6 will repeat visit 2.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment EA-KAFO, P.REX, Agilik, EA-KAFO for cerebral palsy?
Research shows that different types of ankle-foot orthoses (braces) can improve walking patterns in children with cerebral palsy, although no single type is proven to be the best. Articulated braces, which allow some movement, are often preferred by children and can help maintain power in the foot during walking.12345
What makes the EA-KAFO treatment unique for cerebral palsy?
The EA-KAFO (P.REX, Agilik) is a unique treatment for cerebral palsy as it combines a knee-ankle-foot brace with advanced joint designs that may offer improved support and mobility compared to traditional braces. This treatment is particularly novel because it incorporates a genucentric knee joint and a similarly designed ankle joint, which are not typically found in standard braces.12467
Research Team
Thomas C Bulea, Ph.D.
Principal Investigator
National Institutes of Health Clinical Center (CC)
Eligibility Criteria
This trial is for children aged 5-17 with movement disorders like CP, muscular dystrophy, spina bifida, or incomplete spinal cord injury who can walk at least 10 feet and follow simple directions. It's also open to healthy volunteers of the same age. Participants should not have other conditions affecting their ability to walk and must not consume caffeine before EEG assessments.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment and Casting
Initial assessment and casting for custom leg brace
EA-KAFO Configuration and Practice
Participants will wear their new braces, have them adjusted, and practice with different configurations
Accommodation to Brace Configurations
Participants will accommodate to brace configurations and repeat walking and other steps
Final Data Collection
Final data collection and assessment of outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- EA-KAFO (Brace)
EA-KAFO is already approved in Canada for the following indications:
- Cerebral Palsy
- Knee Extension Deficiency
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institutes of Health Clinical Center (CC)
Lead Sponsor
Pius Aiyelawo
National Institutes of Health Clinical Center (CC)
Chief Executive Officer
MPA, FACHE
Dr. Karen Frank
National Institutes of Health Clinical Center (CC)
Chief Medical Officer
MD